Schedule an Appointment
Already a Patient? Connect on My IU Health
- Biography
- Insurance
- Locations
- Specialties & Details
- Ratings & Reviews
- Clinical Trials
- Related Stories
Biography
Dr. Bryan P. Schneider specializes in Breast Care for IUSCC Women's Clinic.
Dr. Schneider currently has a rating of 4.9 stars out of 5 with over 200 ratings. Patients say that he is upbeat, gentle, and genuine.
Dr. Schneider's primary location is IUSCC Women's Clinic, 1030 West Michigan St, Indianapolis, IN 46202.
Insurance
Insurance plans accepted by this provider are below.
Blue Cross and Blue Shield
Community Health Alliance
Deaconess OneCare
First Health Network
Lutheran Preferred
Majestic Care Management I-SNP
Medicaid (Traditional)
Medicare (Traditional)
MultiPlan/PHCS
Physicians Health Plan of Northern Indiana (PHP)
Sagamore Health Network
SHO Direct
Southern Indiana Health Organization (SIHO) Inspire/PPO
VA Community Care Network
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Locations
Specialties & Details
Specialties:
Hematology - Oncology
Conditions & Treatments:
Breast Cancer, Precision Genomics
Education
Internship:
Indiana University School of Medicine, Indianapolis, IN
Residency:
Indiana University School of Medicine, Indianapolis, IN
Hospitals & Affiliations
Hospital Privileges:
IU Health Methodist/IU Health University, IU Health North
Physician Group:
IU Health Medical Group
Research
Research Publications
* Information provided by PubMed
Related Services
Ratings & Reviews
Overall Provider Rating
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
Total Cancer Care: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer
View DetailsA Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
View DetailsCirculating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
View DetailsRelated Stories
Patient Stories
Read More
Mother, daughter diagnosed with breast cancer four weeks apart
IU Health Simon Cancer Center — Kathlyn “Kathie” West is the third generation of w...
Patient Stories
Read More
Mother, grandmother receives treatment for breast cancer
IU Health Simon Cancer Center — Tammie Cornelous is putting her trust in IU Health...